ARK Genomic Revolution ETF (ARKG) Holdings $23.93 +0.32 (+1.36%) Closing price 06/16/2025 03:58 PM EasternExtended Trading$23.82 -0.11 (-0.44%) As of 06:13 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Holdings Stock AnalysisChartHeadlinesHoldingsOwnershipRatingsBuy This Stock Top 33 ARKG HoldingsRankCompanyCurrent PriceWeightShares Held1TEMTempus AI$72.00+1.0%10.61%1,496,5452CRSPCRISPR Therapeutics$41.58+0.5%8.36%2,025,1523TWSTTwist Bioscience$35.04+4.5%7.14%2,056,9054GHGuardant Health$49.30+0.0%6.11%1,298,7995NTRANatera$168.25+1.8%5.82%323,8806RXRXRecursion Pharmaceuticals$5.00+1.6%5.50%11,261,6247SDGRSchrödinger$21.20-1.1%4.57%1,887,3738ADPTAdaptive Biotechnologies$10.29-0.3%4.31%4,039,7919CDNACareDx$19.07+2.6%3.85%2,018,16010PSNLPersonalis$6.45+7.3%3.70%6,846,411 Get the Latest News and Ratings for ARKG and Related StocksEnter your email address below to receive the latest news and analysts' ratings for ARK Genomic Revolution ETF and its competitors with MarketBeat's FREE daily newsletter. 11BEAMBeam Therapeutics$16.62-2.6%3.42%1,892,31612VCYTVeracyte$26.64+0.8%3.42%1,146,04713TXG10x Genomics$11.01+5.8%3.37%3,189,37214IONSIonis Pharmaceuticals$35.24-1.0%3.30%865,65715ABSIAbsci$2.82+1.4%2.85%9,328,25916ARCTArcturus Therapeutics$12.87+4.0%2.36%1,649,91117ILMNIllumina$90.25+3.8%2.36%260,02318NTLAIntellia Therapeutics$8.96+7.8%2.27%2,833,63319NRIXNurix Therapeutics$11.91-0.2%2.05%1,511,45020AMGNAmgen$295.56+0.1%1.79%55,66521MASS908 Devices$7.19-1.6%1.69%2,547,42922BFLYButterfly Network$2.32+0.7%1.59%6,169,66123VEEVVeeva Systems$284.24+0.6%1.49%47,86624QSIQuantum-Si$1.77+6.6%1.44%7,657,51325PACBPacific Biosciences of California$1.38+15.0%1.19%10,821,08626VRTXVertex Pharmaceuticals$450.91-1.0%1.15%23,09627INCYIncyte$71.22+5.1%1.08%147,55328CERSCerus$1.41+6.8%0.99%6,690,53929CMPSCOMPASS Pathways$4.64+5.7%0.77%1,586,12630REGNRegeneron Pharmaceuticals$522.68-1.2%0.66%12,07831LABStandard BioTools$1.10+4.8%0.36%3,034,28332PRMEPrime Medicine$1.50+2.7%0.30%2,232,63233GOLDMAN FS TRSY OBLIG INST 468N/A0.12%1,100,686 Geographic ExposureUnited States90.9%Switzerland8.6%Currency ExposureUSD99.6%Sector ExposureHealth Care85.5%Consumer Discretionary6.6%Information Technology6.1%Technology1.4%Industry ExposureBiotechnology42.5%Life Sciences Tools & Services24.2%Health Care Equipment & Supplies13.4%Diversified Consumer Services6.6%Health Care Providers & Services5.5%IT Services4.2%Electronic Equipment, Instruments & Components1.9%Software1.4%SubIndustry ExposureBiotechnology42.5%Life Sciences Tools & Services31.3%Health Care Equipment6.2%Health Care Services5.5%Internet Services & Infrastructure4.2%Electronic Equipment & Instruments1.9%Application Software1.4%Coupon Exposure4-60.1% Related Companies and Tools Related Companies Amplify Transformational Data Sharing ETF Portfolio iShares Future AI & Tech ETF Portfolio iShares MSCI ACWI Low Carbon Target ETF Portfolio ROBO Global Robotics & Automation ETF Portfolio ARK Autonomous Technology & Robotics ETF Portfolio iShares Cybersecurity and Tech ETF Portfolio ARK Fintech Innovation ETF Portfolio Global X S&P 500 Catholic Values ETF Portfolio iShares ESG MSCI USA Leaders ETF Portfolio iShares Core Dividend ETF Portfolio This page (BATS:ARKG) was last updated on 6/17/2025 by MarketBeat.com Staff From Our PartnersThe End of Elon Musk…?The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, an...Brownstone Research | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredNew Rule Hits in July — The Smart Money Already MovedA little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Stre...American Alternative | SponsoredWhy July 22nd Could Mean Big Changes for Social SecurityIn a stunning move, President Trump has authorized an AI-led transformation of federal agencies, including Soc...Altimetry | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Robots aren't coming to America in 2025. They are already here. Oxford Economics says, "The Robotics Rev...Weiss Ratings | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredWill I be blacklisted?The President’s tour of the Middle East… the deal for Ukraine’s mineral rights… Elon’s strange time in Washing...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ARK Genomic Revolution ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share ARK Genomic Revolution ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy ARKG Stock Free ARKG Stock Alerts